Vomiclose 1mg Injection
Marketer
Bennet Pharmaceuticals Limited
Salt Composition
Granisetron (1mg)
Overview Vomiclose 1mg Injection
Antiemetic medication, Vomiclose 1mg Injection, effectively manages postoperative nausea and vomiting, as well as that stemming from cancer treatments (chemotherapy and radiotherapy). However, it does not address other cancer therapy side effects. Administered by a healthcare provider, the injection should be used precisely as directed. Continued use, as determined by your physician, is crucial. Subsequent treatment may transition to oral medication. Common side effects, such as injection site discomfort, headache, bowel irregularities (constipation or diarrhea), and fatigue, typically subside upon cessation of treatment. Persistent or bothersome symptoms warrant discussion with your doctor, who can offer management strategies. Prior to use, inform your doctor of any pre-existing heart or liver conditions, gastrointestinal obstructions, or current medications, particularly those for epilepsy, cardiac issues, cancer, or depression, as interactions are possible. Consult your healthcare provider regarding use during pregnancy or breastfeeding.
Uses of Vomiclose 1mg Injection
Chemotherapy-induced emesis
Major Benefits of Vomiclose 1mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Vomiclose 1mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Vomiclose 1mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Vomiclose 1mg Injection works:
Vomiclose 1mg Injection, an antiemetic, counteracts nausea and vomiting. This effect is achieved by inhibiting serotonin, a neurotransmitter in the brain that can trigger these symptoms following surgery or cancer therapy (chemotherapy).
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vomiclose 1mg Injection may pose unknown risks. A physician's advice is recommended.
PregnancySAFE IF PRESCRIBED
The injectable medication Vomiclose, 1mg dose, is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Vomiclose 1mg Injection without significant risk to their infants. Available human data indicates minimal danger to the baby.
DrivingSAFE
Administering a 1mg Vomiclose injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
Vomiclose 1mg Injection appears to be safely administered to individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Vomiclose 1mg Injection appears safe for use in individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Vomiclose 1mg Injection :
Should you forget a dose of Vomiclose 1mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vomiclose 1mg Injection
| Label | Value |
|---|---|
| Chemical Category | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | 5-HT3 receptor blockers |
3,018 People bought this recently